Text Size

Bronchopulmonary Disease (BPD) Patient Registry (CHILD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Children's Hospital Boston.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00951366
First received: August 3, 2009
Last updated: NA
Last verified: August 2009
History: No changes posted
  Purpose

The goal of the Bronchopulmonary Dysplasia (BPD) Patient Registry is to collect data on individuals with neonatal lung disease to better understand the illness and ultimately improve their care and survival. The Patient Registry was established in 2008 as a means to monitor important trends in the BPD population and to improve understanding, treatment, and survival.


Condition Intervention
Bronchopulmonary Disease
 Other: Patient Registry

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: The Center for Healthy Infant Development (Child) Clinic Patient Registry

Further study details as provided by Children's Hospital Boston:

Estimated Enrollment: 360
Study Start Date: June 2008
Groups/Cohorts Assigned Interventions
Bronchopulmonary Dysplasia (BPD) Other: Patient Registry
The BPD Patient Registry is used by both clinicians and researchers to better understand BPD and to improve care of individuals with BPD.

Detailed Description:

The BPD Patient Registry is used by both clinicians and researchers to better understand BPD and to improve care of individuals with BPD. Each year the data in the Patient Registry will be analyzed and an annual report of BPD health trends will be created. Using this information, BPD clinicians can address quality improvement initiatives, and examine changing health care issues, including nutritional status, infection control, pulmonary treatment and/or metabolic issues rapidly and effectively. The Patient Registry will also play an important role in directing clinical care and in the design of clinical research studies. Researchers use the registry to help in investigating various aspects of neonatal lung diseases like BPD, including medications, diagnostic procedures, and eligibility for clinical trials.

  Eligibility

Ages Eligible for Study:   up to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Bronchopulmonary Dysplasia (BPD) patients will be approached during clinical visit and inpatient hospitalizations.

Criteria

Inclusion Criteria:

  • Bronchopulmonary Dysplasia (BPD)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00951366

Locations
United States, Massachusetts
Children's Hosptital, Boston Recruiting
Boston, Massachusetts, United States, 02115
Contact: Lawrence Rhein, MD     617-355-3185     lawrence.rhein@childrens.harvard.edu    
Principal Investigator: Lawrence Rhein, MD            
Sponsors and Collaborators
Children's Hospital Boston
  More Information

No publications provided

Responsible Party: Lawrence Rhein, MD, Children's Hospital, Boston
ClinicalTrials.gov Identifier: NCT00951366     History of Changes
Other Study ID Numbers: X08-07-0335
Study First Received: August 3, 2009
Last Updated: August 3, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital Boston:
For clinicians and researchers to better understand BPD
To improve care of individuals with BPD
To examine quality improvement initiatives
To examine changing health care issues
To determine eligibility of clinical research studies

ClinicalTrials.gov processed this record on May 23, 2013